Stockcalc – Free Trial
Have a free look inside the StockCalc website at www.stockcalc.com
Trading at Less than Cash Value
Today we are looking at companies trading at less than cash value meaning companies whose current share price is less than the cash per share on the balance sheet. We also show the value of cash net debt per share to show how much cash per share would be left if the debt was paid off.
What this Means…
Companies can have more cash per share than the actual share price for a number of reasons including they just raised capital, are in industries that experience high burn rates and will eat through the cash quickly or if there is a lot of uncertainty about the future of the company. Companies earning a positive net income will have a P/E greater than 0 and are worth exploring in more detail.
Today’s Data on AMEX
Today’s data is for companies listed on the American Stock Exchange.
|Symbol||Name||Close Price||Shares Outstanding||P/E||P/B||Cash per Share||Net Cash per Share|
|LEU||Centrus Energy Corp||2.210000||9038751||None||None||15.50||-1.68|
|HMG||HMG/Courtland Properties Inc||14.250000||1013292||3.0306||0.6407||19.49||18.17|
|TKAT||Takung Art Co Ltd||0.678000||11226025||None||0.4410||0.92||0.28|
|SYN||Synthetic Biologics Inc||0.883500||7208320||None||None||0.99||0.64|
|APHB||Ampliphi Biosciences Corp||0.326200||16468308||0.9885||0.6442||0.35||0.31|
Let’s look at a few companies…
Lets look at a couple of the companies on this list to get a better understanding of them.
TKAT:ASE Takung Art Co
Takung Art Co has 117 employees and is headquartered in Hong Kong.
Takung Art Co Ltd along with its wholly owned subsidiary, operates an electronic online platform located at www.takungae.com for artists, art dealers and art investors to offer and trade in valuable artwork.
SYN:ASE Synthetic Biologics
Synthetic Biologics has 25 employees and is headquartered in United States.
Synthetic Biologics Inc is a late-stage biotechnology company focused on developing gut microbiome therapeutics. It is also developing monoclonal antibody therapies for the treatment of pertussis.
The content presented here is in part from the website stockcalc.com and is provided on an as is or as available basis with all faults and may not be current in all cases. You should not rely on any of the information as authoritative or as a substitute for the exercise of your own skill and judgment in making an investment decision.